← Back to Search

Behavioral intervention one for Muscle Cramps (RELAX Trial)

N/A

Waitlist Available

Led By Elliot Tapper, MD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 35 days

Awards & highlights

RELAX Trial Summary

This trial is testing two interventions for reducing nighttime lower body muscle cramps. One group will do gentle stretching exercises before bed, and the other will take a supplement called quinine sulfate.

Eligible Conditions

Muscle Cramps
Muscle Cramp

RELAX Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 35 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~35 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 35 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in cramp severity after 35-days as measured by the Visual Analog Scale for Cramps

Secondary outcome measures

Change in sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI).

Patient global impression of change (PGIC)

RELAX Trial Design

2Treatment groups

Experimental Treatment

Group I: Behavioral intervention twoExperimental Treatment1 Intervention

Group II: Behavioral intervention oneExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Behavioral intervention one

2022

N/A

~100

Behavioral intervention two

2022

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,795 Previous Clinical Trials

6,373,837 Total Patients Enrolled

Elliot Tapper, MDPrincipal InvestigatorUniversity of Michigan

4 Previous Clinical Trials

242 Total Patients Enrolled

Media Library

Behavioral intervention one Clinical Trial Eligibility Overview. Trial Name: NCT05457322 — N/A

Muscle Cramps Research Study Groups: Behavioral intervention one, Behavioral intervention two

Muscle Cramps Clinical Trial 2023: Behavioral intervention one Highlights & Side Effects. Trial Name: NCT05457322 — N/A

Behavioral intervention one 2023 Treatment Timeline for Medical Study. Trial Name: NCT05457322 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts currently underway for this experiment?

"Affirmative. Clinicaltrials.gov specifies that this research study, which was posted on August 30th 2022, is actively recruiting volunteers. The trial is seeking 100 participants from 6 different medical centres."

Answered by AI

How large is the cohort of individuals participating in this research?

"To complete this clinical trial, 100 qualified individuals need to be enrolled. The two primary sites for patient recruitment are the University of Miami Health System in Florida and Beth Israel Deaconess Medical Centre in Boston."

Answered by AI

Are multiple locations within the state engaging in this clinical research?

"This trial is presently being carried out in 6 localised sites, such as Miami, Boston and Ann Arbor. It would be prudent to choose the closest clinical site possible to lessen travel obligations if you decide to take part."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

Elliot B. Tapper 2022. "The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05457322.